Jacqueline Garcia, Md

This study is testing the safety of adding a drug called venetoclax to the standard treatment given before a bone marrow transplant for people with high-risk blood cancers like AML and MDS. It also tests giving venetoclax with other drugs after the transplant to try to prevent th…

This early-stage study aims to find a safe dose for a new combination of three drugs (navitoclax, venetoclax, and decitabine) to treat aggressive forms of blood and bone marrow cancers. It will enroll about 36 adults with specific high-risk conditions like acute myeloid leukemia …